Cargando…

Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy

Detalles Bibliográficos
Autores principales: Pettengell, R., Schwenkglenks, M., Bosly, A.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275304/
https://www.ncbi.nlm.nih.gov/pubmed/18299833
http://dx.doi.org/10.1007/s00277-008-0447-2
_version_ 1782151853917601792
author Pettengell, R.
Schwenkglenks, M.
Bosly, A.
author_facet Pettengell, R.
Schwenkglenks, M.
Bosly, A.
author_sort Pettengell, R.
collection PubMed
description
format Text
id pubmed-2275304
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-22753042008-03-26 Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy Pettengell, R. Schwenkglenks, M. Bosly, A. Ann Hematol Letter to the Editor Springer-Verlag 2008-02-26 2008-05 /pmc/articles/PMC2275304/ /pubmed/18299833 http://dx.doi.org/10.1007/s00277-008-0447-2 Text en © The Author(s) 2008
spellingShingle Letter to the Editor
Pettengell, R.
Schwenkglenks, M.
Bosly, A.
Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy
title Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy
title_full Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy
title_fullStr Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy
title_full_unstemmed Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy
title_short Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy
title_sort association of reduced relative dose intensity and survival in lymphoma patients receiving chop-21 chemotherapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275304/
https://www.ncbi.nlm.nih.gov/pubmed/18299833
http://dx.doi.org/10.1007/s00277-008-0447-2
work_keys_str_mv AT pettengellr associationofreducedrelativedoseintensityandsurvivalinlymphomapatientsreceivingchop21chemotherapy
AT schwenkglenksm associationofreducedrelativedoseintensityandsurvivalinlymphomapatientsreceivingchop21chemotherapy
AT boslya associationofreducedrelativedoseintensityandsurvivalinlymphomapatientsreceivingchop21chemotherapy